Loop Industries Announces Q2 Results, Rescales India Facility
Loop Industries reports second quarter results and plans to expedite its India facility's development, rescaling it to 45 KTA to reduce costs.
Twin Vee PowerCats Enters Amended Merger Agreement with USFM
Twin Vee PowerCats announces an amended merger agreement with USFM Corporation, signaling a significant move in the ship and boat building industry.
Decoy Therapeutics files S-1 for public offering
Decoy Therapeutics has filed an S-1 registration statement, signaling plans for a public offering to raise capital for its pharmaceutical developments.
Centinel Spine Holdco, Inc. Files for Initial Public Offering
Centinel Spine Holdco, Inc. has filed for an initial public offering, signaling growth potential in the Surgical & Medical Instruments & Apparatus industry.
SPACSphere Acquisition Corp. Amends Business Combination Agreement
SPACSphere Acquisition Corp. amends its agreement with Mobilewalla, expanding its board and preparing for a significant business transition.
KiNRG, Inc. files amended registration statement for capital
KiNRG, Inc. files an amended registration statement, signaling progress in its capital-raising efforts amid evolving market conditions in the heavy construction sector.
FireFly Robotics files S-1 registration statement for IPO
FireFly Robotics, Inc. has filed an S-1 registration statement, signaling plans for a public offering to raise capital and expand in the farm machinery sector.
Non Invasive Monitoring Systems files amended registration statement
Non Invasive Monitoring Systems Inc. files an amended registration statement, highlighting its efforts to secure funding in the guided missiles and space vehicles industry.
Winklevoss Zcash ETF files for securities registration
Winklevoss Zcash ETF has filed for securities registration, marking a significant step toward launching a cryptocurrency-focused exchange-traded fund.
Fusemachines Inc. files S-1 for potential public offering
Fusemachines Inc. has filed an S-1 registration statement, signaling its intent to go public and expand its market presence in the tech industry.
Kainan Holding Group files amended registration statement
Kainan Holding Group Ltd has filed an amended registration statement, indicating ongoing efforts to raise capital through public offerings.
Crescent Energy amends credit agreement for Devon acquisition
Crescent Energy Co has amended its credit agreement to facilitate the acquisition of Devon Energy assets, signaling strategic growth in the crude petroleum sector.
Anavex Receives FDA Approval for Blarcamesine Study
Anavex Life Sciences Corp. receives FDA clearance for its clinical study of blarcamesine in Fragile X syndrome, marking a milestone for the company.
Silentium Ltd. files amended registration statement for IPO
Silentium Ltd. files an amended registration statement, signaling progress toward an IPO in the prepackaged software industry.
Evolution Metals files S-1 registration statement for growth
Evolution Metals & Technologies Corp. filed an S-1, signaling plans for capital raising to enhance its growth in the electrical machinery sector.
New Iceland Arctic Acquisition Corp. files amended S-1 registration
New Iceland Arctic Acquisition Corp. has filed an amended S-1 registration statement, signaling progress in its public offering plans.
Indivior stockholders approve share issuance for merger
Indivior Pharmaceuticals' stockholders have approved a significant share issuance linked to a merger, marking a key milestone for the company.
Propanc Biopharma files registration statement for securities
Propanc Biopharma, Inc. files a registration statement, marking a key step in its growth strategy in the pharmaceutical preparations sector.
CervoMed reports positive Phase 2a trial results for drug
CervoMed Inc. announces promising Phase 2a trial results for neflamapimod, showing potential in treating primary progressive aphasia.
Lycia Therapeutics files S-1 for potential public offering
Lycia Therapeutics, Inc. files S-1 registration statement, advancing toward a public offering in the competitive biological products sector.